Rodrigo Escobar
About
Rodrigo Escobar is a scholar working on Psychiatry and Mental health, Surgery and Cardiology and Cardiovascular Medicine.
According to data from OpenAlex, Rodrigo Escobar has authored 72 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Psychiatry and Mental health, 17 papers in Surgery and 17 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Rodrigo Escobar's work include Attention Deficit Hyperactivity Disorder (25 papers), Child and Adolescent Psychosocial and Emotional Development (11 papers) and Cardiac and Coronary Surgery Techniques (10 papers). Rodrigo Escobar is often cited by papers focused on Attention Deficit Hyperactivity Disorder (25 papers), Child and Adolescent Psychosocial and Emotional Development (11 papers) and Cardiac and Coronary Surgery Techniques (10 papers). Rodrigo Escobar collaborates with scholars based in Spain, United States and Brazil. Rodrigo Escobar's co-authors include Michel Pompeu Sá, Amaia Hervás, Inmaculada Gilaberte, Alonso Montoya, Ricardo de Carvalho Lima, César A. Soutullo, Xavier Gastaminza, Pepa Polavieja, Cecília Andrade Santos and Alexander Schacht and has published in prestigious journals such as Journal of the American College of Cardiology, PEDIATRICS and Biological Psychiatry.
In The Last Decade
Rodrigo Escobar
70 papers receiving 1.4k citations
Peers
Rodrigo Escobar
M S Bhatia India
Oliver Riedel Germany
Joseph P. Green United States
Paul Comper Canada
Élaine de Guise Canada
Melissa Nott Australia
Melissa S. Xanthopoulos United States
S. Dikmen United States
Katja Weimer Germany
Deborah L. Ruzicka United States
Citations per year, relative to Rodrigo Escobar Rodrigo Escobar (= 1×)
peers
M S Bhatia
Countries citing papers authored by Rodrigo Escobar
Since
Specialization
Citations
This map shows the geographic impact of Rodrigo Escobar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rodrigo Escobar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rodrigo Escobar more than expected).
Fields of papers citing papers by Rodrigo Escobar
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Rodrigo Escobar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rodrigo Escobar. The network helps show where Rodrigo Escobar may publish in the future.
Co-authorship network of co-authors of Rodrigo Escobar
This figure shows the co-authorship network connecting the top 25 collaborators of Rodrigo Escobar. A scholar is included among the top collaborators of Rodrigo Escobar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rodrigo Escobar. Rodrigo Escobar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Otani, Yuki, Brian G. Feagan, Geert D’Haens, et al.. (2025). Pharmacokinetic Comparability and Safety Between Original and Citrate-Free Mirikizumab Formulations for Subcutaneous Injections: Results from Three Clinical Trials. Advances in Therapy. 42(5). 2369–2384.
2.
Long, Millie D., Stefan Schreiber, Toshifumi Hibi∥, et al.. (2024). Association of Bowel Urgency With Quality-of-Life Measures in Patients With Moderately-to-Severely Active Ulcerative Colitis: Results From Phase 3 LUCENT-1 (Induction) and LUCENT-2 (Maintenance) Studies. Crohn s & Colitis 360. 6(1). otae001–otae001.
3.
D’Haens, Geert, Peter Higgins, Laurent Peyrin‐Biroulet, et al.. (2023). P554 Extended induction response in patients treated with mirikizumab with moderately to severely active ulcerative colitis in the LUCENT trials. Journal of Crohn s and Colitis. 17(Supplement_1). i682–i683.
4.
Tanaka, Yoko, Rodrigo Escobar, & Himanshu P. Upadhyaya. (2017). Assessment of effects of atomoxetine in adult patients with ADHD: consistency among three geographic regions in a response maintenance study. ADHD Attention Deficit and Hyperactivity Disorders. 9(2). 113–120.
5.
Thome, Johannes, Regina Dittmann, Laurence L. Greenhill, et al.. (2017). Predictors of relapse or maintenance of response in pediatric and adult patients with attention-deficit/hyperactivity disorder following discontinuation of long-term treatment with atomoxetine. ADHD Attention Deficit and Hyperactivity Disorders. 9(4). 219–229.
6.
Kuga, Atsushi, et al.. (2017). An observational study of duloxetine versus SSRI monotherapy for the treatment of painful physical symptoms in Japanese patients with major depressive disorder: primary analysis. Neuropsychiatric Disease and Treatment. Volume 13. 2105–2114.
7.
Satoi, Yoichi, et al.. (2016). Treatment discontinuation and tolerability as a function of dose and titration of duloxetine in the treatment of major depressive disorder. Neuropsychiatric Disease and Treatment. 12. 89–89.
8.
Schacht, Alexander, et al.. (2015). Efficacy comparison of duloxetine and SSRIs at doses approved in Japan. Neuropsychiatric Disease and Treatment. 11. 115–115.
9.
Sá, Michel Pompeu, et al.. (2014). Patency of skeletonized versus pedicled internal thoracic artery in coronary bypass graft surgery: A systematic review, meta-analysis and meta-regression. International Journal of Surgery. 12(7). 666–672.
10.
Cardo, Esther, Vibeke Porsdal, Deborah Quail, et al.. (2013). Fast vs. Slow Switching from Stimulants to Atomoxetine in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder. Journal of Child and Adolescent Psychopharmacology. 23(4). 252–261.
11.
Sá, Michel Pompeu, et al.. (2013). Skeletonized versus pedicled internal thoracic artery and risk of sternal wound infection after coronary bypass surgery: meta-analysis and meta-regression of 4817 patients. Interactive Cardiovascular and Thoracic Surgery. 16(6). 849–857.
12.
Upadhyaya, Himanshu P., Lenard A. Adler, Miguel Casas, et al.. (2013). Baseline characteristics of European and non-European adult patients with attention deficit hyperactivity disorder participating in a placebo-controlled, randomized treatment study with atomoxetine. Child and Adolescent Psychiatry and Mental Health. 7(1). 14–14.
13.
Fuentes, Joaquín, Marina Danckaerts, Esther Cardo, et al.. (2013). Long-Term Quality-of-Life and Functioning Comparison of Atomoxetine Versus Other Standard Treatment in Pediatric Attention-Deficit/Hyperactivity Disorder. Journal of Clinical Psychopharmacology. 33(6). 766–774.
14.
Minderaa, Ruud B., Rutger-Jan van der Gaag, Rodrigo Escobar, et al.. (2012). A Randomized Double-Blind Study of Atomoxetine Versus Placebo for Attention-Deficit/Hyperactivity Disorder Symptoms in Children With Autism Spectrum Disorder. Journal of the American Academy of Child & Adolescent Psychiatry. 51(7). 733–741.
15.
Escobar, Rodrigo, et al.. (2012). Preservation versus non-preservation of mitral valve apparatus during mitral valve replacement: a meta-analysis of 3835 patients. Interactive Cardiovascular and Thoracic Surgery. 15(6). 1033–1039.
16.
Sá, Michel Pompeu, et al.. (2011). Risk factors for mediastinitis after coronary artery bypass grafting surgery. Brazilian Journal of Cardiovascular Surgery. 26(1). 27–35.
17.
Escobar, Rodrigo, Alexander Schacht, Peter M. Wehmeier, & Thomas Wagner. (2010). Quality of Life and Attention-Deficit/Hyperactivity Disorder Core Symptoms. Journal of Clinical Psychopharmacology. 30(2). 145–151.
18.
Wehmeier, Peter M., et al.. (2010). Differences between children and adolescents in treatment response to atomoxetine and the correlation between health-related quality of life and Attention Deficit/Hyperactivity Disorder core symptoms: Meta-analysis of five atomoxetine trials. Child and Adolescent Psychiatry and Mental Health. 4(1). 30–30.
19.
Escobar, Rodrigo, Alonso Montoya, Pepa Polavieja, et al.. (2009). Evaluation of Patients' and Parents' Quality of Life in a Randomized Placebo-Controlled Atomoxetine Study in Attention-Deficit/Hyperactivity Disorder. Journal of Child and Adolescent Psychopharmacology. 19(3). 253–263.
20.
Carrasco, José Luís, et al.. (2002). Treatment of severely psychotic inpatients with schizophrenia: olanzapine versus other antipsychotic drugs. International Clinical Psychopharmacology. 17(6). 287–295.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by M S Bhatia Breakdown of academic impact, for papers by Oliver Riedel Breakdown of academic impact, for papers by Joseph P. Green Breakdown of academic impact, for papers by Paul Comper Breakdown of academic impact, for papers by Élaine de Guise Breakdown of academic impact, for papers by Melissa Nott Breakdown of academic impact, for papers by Melissa S. Xanthopoulos Breakdown of academic impact, for papers by S. Dikmen Breakdown of academic impact, for papers by Katja Weimer Breakdown of academic impact, for papers by Deborah L. Ruzicka